ROMVIMZA FDA approval date

The FDA approved ROMVIMZA on 14 Feb 2025.

FDA approval date
14 Feb 2025

Drug identity has not yet been verified against registry records

Also recorded as VIMSELTINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-02-14DayROMVIMZAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219304", "applicant_as_listed_by_fda": "DECIPHERA PHARMS", "brand_names": ["ROMVIMZA"], "active_ingredients": ["VIMSELTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250214", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026